Bromide

Bromide

SCHEMBL6558166

Br.Br.N=C(N)NCc1ccc(C(=O)Nc2ccnc3[nH]ncc23)cc1[N+](=O)[O-].O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
MAPT P10636 2/20 0.39
POLB P06746 2/20 0.39
ALPL P05186 2/20 0.38
HTT P42858 1/20 0.38
SIRT2 Q8IXJ6 2/20 0.36
SIRT1 Q96EB6 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
SIRT3 Q9NTG7 1/20 0.36
CACNA1B Q00975 1/20 0.35
APBA1 Q02410 1/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
TDO2 P48775 2/20 0.35
PKM P14618 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1554284 0.98 ALDH1A1 (0.40) ALDH1A1MAPTPOLBALPLHTT
Bromide SCHEMBL6558127 0.87 MAPT (0.42) ALDH1A1MAPTPOLBALPLHTT
SCHEMBL1553296 0.85 MAPT (0.43) ALDH1A1MAPTPOLBALPLHTT
Bromide SCHEMBL6558055 0.82 MAPT (0.40) ALDH1A1MAPTPOLBALPLHTT
Bromide SCHEMBL6558065 0.82 MAPT (0.40) ALDH1A1MAPTPOLBALPLHTT
SCHEMBL6559915 0.81 HTT (0.41) ALDH1A1MAPTPOLBHTTSMN1; SMN2
SCHEMBL1553049 0.80 MAPT (0.41) ALDH1A1MAPTPOLBALPLHTT
SCHEMBL1553045 0.80 MAPT (0.41) ALDH1A1MAPTPOLBALPLHTT
Hydrochloric Acid SCHEMBL6560004 0.80 HDAC2 (0.46) HTTLMNA
SCHEMBL1553844 0.79 HDAC2 (0.47) HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1391454-A1 Substituted benzamide compounds with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2004-02-25 EP disclosed
EP-1195372-A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity Mitsubishi Pharma Corporation (JP) 2002-04-10 EP disclosed
US-6156766-A Benzamide compounds and pharmaceutical use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2000-12-05 US disclosed
US-5958944-A TREATMENT OF CIRCULATORY DISEASES IN CORONARY, CEREBRAL, RENAL AND PERIPHERAL ARTERIES, AS A THERAPEUTIC AGENT FOR HYPERTENSION, ANGINA PECTORIS, AND RENAL AND PERIPHERAL CIRCULATION DISORDER, ANTIASTHMATIC AGENT YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1999-09-28 US disclosed
EP-0757038-A1 BENZAMIDE COMPOUND AND MEDICINAL USE THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1997-02-05 EP disclosed